Browse News
Filter News
Found 517,292 articles
-
Novo Nordisk is laying off 400 staffers so it can shift funds toward biological and technological innovation.
-
Allergan and its development partner Sosei Group have voluntarily suspended clinical trials of HTL0018318 in Alzheimer’s and other types of dementia because of safety problems.
-
In a 99 to 1 vote, the Senate passed the bill that looks to cut down on the flow of illegal narcotics entering the United States through the mail, as well as taking aim at the abuse of prescription opioid medication – a problem that has grown to an epidemic in the United States.
-
San Diego-based Viking Therapeutics announced positive top-line data from a 12-week Phase II clinical trial of VK2809 in non-alcoholic fatty liver disease (NAFLD) and elevated low-density lipoprotein cholesterol (LDL-C).
-
A second former GlaxoSmithKline scientist has pled guilty to stealing trade secrets as part of a scheme to benefit a startup China-based pharmaceutical company he helped establish.
-
House Rejects Senate Bill Provision to Require Disclosure of Drug Prices in Television Commercials
9/18/2018
The U.S. House of Representatives has split with the Senate over requiring pharmaceutical companies to disclose the list price of their prescription medications in television advertisements. -
As Novartis looks to regain its reputation following a series of ethical blunders, the company unveiled a new ethics scoring system that will be tied to employee bonuses.
-
Hemophilia patients could have an easier time taking their medication if the U.S. Food and Drug Administration gives the green light for the newest formulation of Genentech’s Hemlibra.
-
In March, U.S. insurer Cigna Corporation announced it was acquiring pharmacy benefits manager Express Scripts for approximately $52 billion. On Monday, the Department of Justice (DOJ) approved the merger.
-
According to the 2017 Mind the Workplace report by Mental Health America, 71% of workers in the U.S. were either actively looking for new job opportunities or had the topic on their mind always, often, or sometimes while at work. Regardless of all of the potential causes of these feelings, we se...
-
BioTime Implements New Leadership Structure; Appoints Brian Culley as Chief Executive Officer
9/18/2018
Former Co-CEO Adi Mohanty to Aid in Transition and Continue to Serve on the Boards of Asterias and OncoCyte
-
European Medicines Agency Validates Bristol-Myers Squibb’s Application for Empliciti (elotuzumab) Plus Pomalidomide and Low-Dose Dexamethasone in Patients with Multiple Myeloma
9/18/2018
Bristol-Myers Squibb Company today announced that the European Medicines Agency (EMA) has validated the Company’s type II variation application for Empliciti (elotuzumab) in combination with pomalidomide and low-dose dexamethasone (EPd) for the treatment of adult patients with multiple myeloma who have received at least two prior therapies
-
OTC Markets Group Welcomes Elixinol Global Limited to OTCQX
9/18/2018
OTC Markets Group Inc. today announced Elixinol Global Limited has qualified to trade on the OTCQX® Best Market.
-
CISCRP Releases New Video on Initiative to Improve Diversity in Clinical Research
9/18/2018
Video captures new outreach and educational program launched in Los Angeles
-
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol
9/18/2018
Study Achieves Primary Endpoint, Demonstrating Statistically Significant Reductions in LDL-C in Patients Receiving VK2809
-
ANSYS 19.2 Delivers Faster Problem-Solving Capabilities Across The Entire Portfolio
9/18/2018
The latest generation of Pervasive Engineering Simulation solutions spurs productivity, efficiency and accuracy for every application
-
SpineVision® Receives CE Mark for Next-Gen P.L.U.S.® Deformity-Correction Spinal System
9/18/2018
A state-of-the-art system of pedicle screws, rods and clip technology specifically designed for treatment of spinal deformity, P.L.U.S. will be introduced to spine surgeons at “EuroSpine 2018” and “NASS 2018”
-
Tilray® Receives Approval from U.S. Government to Import a Medical Cannabis Study Drug for a Clinical Trial at the University of California San Diego Center for Medicinal Cannabis Research
9/18/2018
U.S. Drug Enforcement Administration approves import of a pharmaceutical-grade medical cannabis product produced by Tilray into the United States for a clinical trial focused on Essential Tremor
-
Valeo Pharma and Besins Healthcare Announce Partnership for Utrogestan in Canada
9/18/2018
Valeo Pharma Inc. today announced a strategic agreement to commercialize Utrogestan® (micronised natural progesterone; 200mg vaginal capsules) in Canada.
-
CBR Announces Positive Results for First Study Administering Cord Blood to Children with Hearing Loss
9/18/2018
CBR® has announced the publication of the results of the first clinical trial evaluating the use of autologous umbilical cord blood in children with acquired sensorineural hearing loss (SNHL).